Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis

Joseph R. Mikhael, Steven R. Schuster, Victor H. Jimenez-Zepeda, Nancy Bello, Jacy Spong, Craig B. Reeder, A. Keith Stewart, P. Leif Bergsagel, Rafael Fonseca

Research output: Contribution to journal › Article › peer-review

249 Scopus citations

Fingerprint

Dive into the research topics of 'Cyclophosphamide-bortezomib-dexamethasone (CyBorD) produces rapid and complete hematologic response in patients with AL amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds